References
- K.A. Boris-Lawrie and H.M. Temin, Recent advances in retrovirus vector technology, Curr. Opin. Genet. Dev., 3, 102-109 (1993) https://doi.org/10.1016/S0959-437X(05)80349-1
- T.A. Smith, M.G. Mehaffey, D.R. Kayda, J.M. Saunders, S. Yei, R.C. Trapnell, A. McClelland and M. Kaleko, Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice, Nature Genet., 5, 397-402 (1993) https://doi.org/10.1038/ng1293-397
- Y. Setoguchi, H.A. Jaffe, C.-S. Chu and R.G. Crystal, Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation, Am. J. Resp. Cell Mol. Bioi., 10, 369-377 (1994) https://doi.org/10.1165/ajrcmb.10.4.8136153
- Y. Yang, F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol and J.M. Wilson, Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy, Proc. Natl. Acad. Sci. USA, 91, 4407-4411 (1995)
- Y. Yang, Q. Li, H.C.J. Erte and J.M. Wilson, Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses, J. Virol., 69, 2004-2015 (1995)
- A.D. Miller, Retrovirus vector, Curr. Top. Microbiol. Immunol., 158, 1-23 (1992)
- S. Worgall, G. Wolff, E. Falck-Pedersen and R.G. Crystal, Nonimmune mechanisms dominate elimination of adenovirus vectors following in vivo administration, Hum. Gene Ther., 8, 37-44 (1997) https://doi.org/10.1089/hum.1997.8.1-37
- B.T. Lamb, S.S. Sisodia, A.M. Lawler, H.H. Slunt, C.A. Kitt, W.G. Keams, P.L. Pearson, D.L. Price and J.D. Gearhart, Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice, Nature Genet., 5, 22-30 (1993) https://doi.org/10.1038/ng0993-22
- S. Li and L. Huang, Nonviral gene therapy: promises and challenges, Gene Ther., 7, 31-34 (2000) https://doi.org/10.1038/sj.gt.3301110
- A.G. Schatzle in Non-viral vectors in cancer gene therapy: principles and progress, Anti-Cancer Drugs, 12, 275-304 (2001) https://doi.org/10.1097/00001813-200104000-00001
- G.S. Harrison, Y. Wang, J. Tomezak, C. Hogan, E.J. Shpall, T.J. Curiel and P.L. Felgner, Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34 hematopoietic cells, Biotechniques, 19, 816-823 (1995)
- C.M. Ward, M.L. Read and L.W. Seymour, Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy, Blood, 97, 2221-2229 (2001) https://doi.org/10.1182/blood.V97.8.2221
- A. Kiehler, Gene transfer with modified polyethylenimines, J. Gene Med, 6, S3-S10 (2004) https://doi.org/10.1002/jgm.507
- E. Piskin, S. Dincer and M. Turk, Gene delivery: intelligent but just at the beginning, J. Biomater. Sci., 15, 1181-1202 (2004) https://doi.org/10.1163/1568562041753016
- D. Paphajopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.-D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann and F.J. Marin, Sterically stabilized liposomes: improvement in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad Sci. USA, 88, 11460-11464(1991)
- N. Shi and W.M. Pardridge, Noninvasive gene targeting to the brain, Proc. Natl. Acad. Sci. USA, 97, 7567-7572 (2000)
- P.-A. Monnard, T. Oberholzer and P.L. Luisi, Entrapment of nucleic acids in liposomes, Biochim. Biophys. Acta, 1329, 39-50 (1997) https://doi.org/10.1016/S0005-2736(97)00066-7
- J. Huwyer, W. Dafang and W.M. Pardridge, Brain drug delivery of small molecules using immunoliposomes, Proc. Natl. Acad. Sci. USA, 93, 14164-14169 (1996)
- E.G. Sarabolac, O. Ludkovski, R. Skirrow, M. Ossanlou, Y.P. Zhang, C. Giebrecht, J. Thompson, S. Thomas, H. Stark, P.R. Cullis and P. Scherrer, Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity, J. Drug Target, 7, 423-437 (2000) https://doi.org/10.3109/10611860009102217
- K. Maruyama, O. Ishida, T. Takizawa and K. Moribe, Possibility of active targeting to tumor tissue with liposomes, Adv. Drug Deliv. Rev., 40, 89-102 (1999) https://doi.org/10.1016/S0169-409X(99)00042-3